1. In Vivo
  2. >>Global Vision

Vietnam On The Verge Of Change

Vietnam’s pharma market has seen constant growth over the last decade, driven by rising incomes and an aging population. Spending on drugs is expected to rise by more than 10% in 2021.

Vietnam Map

The sales revenue of Vietnam's pharma market has been growing constantly over the last decade, reaching $6.4bnin 2020, 2% up y-o-y. Top 5 growth contributors in 2020 were immunosuppressants (40%), vaccines (36%), topical anti rheumatics (34%), antineoplastics (13%) and diabetes treatments (11%). Top 4 growth inhibitors were antivirals for systemic use (-20%), intravenous solutions (-17%), systemic antibacterials (-8%) and cholagogues and hepatic protectors (-7%).

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Global Vision

More from In Vivo

Podcast: Ochre Bio’s Approach To Precision Medicine In Liver Treatment

 
• By David Wild

Ochre Bio co-founder and CSO Quin Wills spoke with In Vivo about the UK-based company's novel approach to finding RNA therapies for chronic liver disease.

Richard DiMarchi On The GLP-1 Revolution: An Overnight Success After 40 Years

 
• By Andrew Warmington

As GLP-1 agonists surge to blockbuster status transforming diabetes and obesity treatment, Richard DiMarchi, the pioneering scientist behind their development, recounts the inside story of the drug class in a fireside chat.

Rising Leaders 2025: João Ribas On Building At The Intersection Of Science And Business

 
• By Jo Shorthouse

João Ribas combines scientific expertise with venture capital at Novo Holdings, applying his dual background to develop biotech investments that connect academic research with commercial opportunity.